Because ErbB2 was reported to be expressed in chondrocytes and GDF15 was observed to interact with this receptor in ovarian cancer, we demonstrated that this interaction was conserved in chondrocytes and may have partially explained the mechanism of the GDF15/MAPK14 signaling pathway. The gene discussed is ERBB2; the disease is ovarian carcinoma.